Schonfeld Strategic Advisors LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 218 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$470,000
+71.8%
11,750
+88.6%
0.00%
+50.0%
Q1 2024$273,515
-40.5%
6,229
-62.0%
0.00%
-50.0%
Q4 2022$459,472
-50.3%
16,398
-50.2%
0.00%
-50.0%
Q3 2022$924,000
+241.0%
32,900
+321.8%
0.01%
+166.7%
Q2 2022$271,000
-66.4%
7,800
-65.3%
0.00%
-57.1%
Q1 2022$807,000
-40.4%
22,500
-67.9%
0.01%
-78.8%
Q4 2019$1,354,000
+278.2%
70,179
+312.8%
0.03%
+153.8%
Q2 2019$358,000
-59.7%
17,000
-60.9%
0.01%
-58.1%
Q1 2019$888,000
+88.9%
43,500
+70.2%
0.03%
-49.2%
Q4 2016$470,00025,5610.06%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
MQS Management LLC 10,935$255,0000.41%
GLOBEFLEX CAPITAL L P 144,692$3,370,0000.34%
CORNERCAP INVESTMENT COUNSEL INC 58,975$1,374,0000.20%
Factorial Partners, LLC 10,900$254,0000.17%
FEDERATED HERMES, INC. 3,464,335$80,684,0000.15%
Campbell & CO Investment Adviser LLC 14,800$345,0000.12%
FULLER & THALER ASSET MANAGEMENT, INC. 611,462$14,241,0000.08%
Summit Global Investments 45,900$1,069,0000.07%
RENAISSANCE GROUP LLC 63,559$1,480,0000.06%
PDT Partners, LLC 33,459$779,0000.06%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders